Here's What to Expect From J. M. Smucker’s Next Earnings Report

Orrville, Ohio-based The J. M. Smucker Company (SJM) is a leading consumer packaged goods company that manufactures and markets branded food, beverages, and pet food products across North America. Valued at a market cap of $13.1 billion, its portfolio includes popular brands such as Folgers and Café Bustelo coffee, Jif peanut butter, Smucker’s fruit spreads, Uncrustables frozen sandwiches, Hostess snack cakes, Milk-Bone dog treats, and Meow Mix cat food. 

The company is expected to release its Q2 2027 earnings soon. Ahead of the event, analysts expect the company’s EPS to be $2.50 on a diluted basis, up 19.1% from $2.10 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in three of its last four quarters, while missing on one occasion.

For fiscal 2027, analysts project the company’s EPS to be $10.71, up 17.1% from $9.15 in fiscal 2026. Moreover, its EPS is expected to rise by roughly 1.9% year over year to $10.91 in fiscal 2028.   

SJM stock has grown 19.7% over the past 52 weeks, outpacing both the S&P 500 Index’s ($SPX) 12.4% rise and the State Street Consumer Staples Select Sector SPDR ETF’s (XLP), which rallied 10.7% during the same time frame.    

J.M. Smucker has outperformed the broader market over the past year, driven by stronger-than-expected quarterly earnings, resilient organic sales growth, and improving investor sentiment.

On Oct. 23, The J.M. Smucker’s board of directors approved a dividend of $1.12 per share for common shareholders, with payment scheduled for Dec. 1, 2026. Shareholders must be on record by Nov. 13, 2026, to qualify for the payout, reflecting the company’s continued commitment to returning capital to investors through regular dividend payments.

Analysts are moderately bullish on SJM, with the stock having a “Moderate Buy” rating overall. Among the 18 analysts covering the stock, nine are recommending a “Strong Buy,” two suggest a “Moderate Buy,” and seven suggest a “Hold” for the stock. Its average analyst price target is $141.06, indicating an upside of 12.4% from the current levels. 

On the date of publication, Kritika Sarmah did not directly have a position in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.